India to share open-source version of CoWIN to 50 countries

Science    29-Jun-2021
Total Views |
New Delhi, June 29:: Looking at the massive demand for the CoWIN platform in various countries, Prime Minister Narendra Modi directed the authority to create an open-source version of CoWIN free of cost for any interested country. Dr. R S Sharma, the chairman of the empowered group for Covid-19 vaccine administration on Thursday informed about it during the 2nd Public Health Summit 2021.
 
COWIN_1  H x W:
 
He said that the Cowin platform has become so popular that as many as 50 countries from Central Asia, Latin America, Africa all showed interest in having a Co-win like system. He added that Prime Minister Narendra Modi has directed officials to create an open-source version of the platform and give it free of cost to any country that wants it.

 
Sharma took to Twitter and wrote, "CoWIN has become popular! Over 50 countries from across Central Asia, Latin America and Africa, are interested in this technology. PMO (Prime Minister's Office) has directed us to create an open-source version of CoWIN free of cost for any interested country."
 
 
 
 
He also said a virtual global conclave of health and technology experts from across the world will be held on July 5 where India will share how this system works. “We are telling the world how this system can work and how we are ready to share an open-source software with any country free of cost. There have been huge interests starting from Canada, Mexico, Panama, Peru, Azerbaijan, Ukraine, Nigeria, Uganda," he said.
 
Other countries such as Vietnam, Iraq, Dominican Republic, the United Arab Emirates have also expressed interest in knowing about the Co-WIN platform for implementing it in their own countries to run their COVID programs.
 
 
The CoWIN platform is used to drive India's Covid-19 vaccine registration and appointment booking for all adults aged above 18. It also provides a comprehensive dashboard detailing the breakup of total inoculations carried out so far across states, demographics, genders, and vaccine types.